Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Unger

Showing results (41-50 of 446) with videos related to

Pageof 45
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 1, 1990
Development of genetic hypertension. Is there a "critical phase"?T Unger, R Rettig
The EMBO Journal|June 1, 1990
The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive elementT Unger, Y Shaul
American Journal of Hypertension|January 5, 2000
Angiotensin II receptor blockade and end-organ protectionO Chung, T Unger
Health Data Management|September 22, 2001
Readers perspectives. The deadlines for complying with rules stemming from the Health Insurance Portability and Accountability Act, or HIPAA, should not be delayedS Viland, T Unger
The American Journal of Cardiology|November 24, 1995
Chronic low-dose treatment with perindopril improves cardiac function in stroke-prone spontaneously hypertensive rats by potentiation of endogenous bradykininP Gohlke, T Unger
Fortschritte Der Medizin|December 19, 1985
[Organization of the National Blood Pressure Program (NBP). Prevention by treatment of risk factors]T Unger, D Ganten
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|September 1, 1976
[Determination of the activity of peptidases and amino acid aryl amidases (author's transl)]T Unger, H Struck
European Heart Journal|June 1, 1992
Central mechanisms regulating blood pressure: circuits and transmittersJ Culman, T Unger
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|January 3, 2007
Angiotensin receptor blocker selectivity at the AT1- and AT2-receptors: conceptual and clinical effectsT Unger, S Sandmann
The American Journal of Cardiology|May 22, 1990
Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitorsT Unger, P Gohlke
Pageof 45

Showing results (41-50 of 446) with videos related to

Sort By:
Pageof 45
Hypertension (Dallas, Tex. : 1979)|December 1, 1990
Development of genetic hypertension. Is there a "critical phase"?T Unger, R Rettig
The EMBO Journal|June 1, 1990
The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive elementT Unger, Y Shaul
American Journal of Hypertension|January 5, 2000
Angiotensin II receptor blockade and end-organ protectionO Chung, T Unger
Health Data Management|September 22, 2001
Readers perspectives. The deadlines for complying with rules stemming from the Health Insurance Portability and Accountability Act, or HIPAA, should not be delayedS Viland, T Unger
The American Journal of Cardiology|November 24, 1995
Chronic low-dose treatment with perindopril improves cardiac function in stroke-prone spontaneously hypertensive rats by potentiation of endogenous bradykininP Gohlke, T Unger
Fortschritte Der Medizin|December 19, 1985
[Organization of the National Blood Pressure Program (NBP). Prevention by treatment of risk factors]T Unger, D Ganten
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|September 1, 1976
[Determination of the activity of peptidases and amino acid aryl amidases (author's transl)]T Unger, H Struck
European Heart Journal|June 1, 1992
Central mechanisms regulating blood pressure: circuits and transmittersJ Culman, T Unger
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|January 3, 2007
Angiotensin receptor blocker selectivity at the AT1- and AT2-receptors: conceptual and clinical effectsT Unger, S Sandmann
The American Journal of Cardiology|May 22, 1990
Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitorsT Unger, P Gohlke
Pageof 45